Clinical Trials in New York State

Showing 1261-1280 of 8,190 trials

Community Pharmacies as Social Determinant of Health Navigators

NCT07278401

Type 1 hybrid effectiveness-implementation study using a quasi-experimental, difference-in-difference (DID) design to deliver a comprehensive social needs screening and navigation program by integrating Community Health Workers (CHWs) into community pharmacies across under-resourced areas in Western New York (WNY).

Social Needs Status

State University of New York at Buffalo1,600 participantsStarted Oct 2025

Buffalo, New York, United States • Buffalo, New York, United States • Buffalo, New York, United States +2 more locations

COMPLETEDPHASE361 miles

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05633355

The primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.

Atopic Dermatitis

Amgen187 participantsStarted Jan 2023

Phoenix, Arizona, United States • Tempe, Arizona, United States • Bryant, Arkansas, United States +74 more locations

Community Pharmacies as Social Determinant of Health Navigators

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Find Trials by Condition in New York State

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

UNITY VCS Vitreoretinal Surgery

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Treatment of Moderate to Severe Refractory Crohn's Disease

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Evaluation of A Clinical Diagnostic Test for CRDS

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant